Table 2. Clinical conditions and groups that benefit from 25-hydroxyvitamin (25[OH]D) concentrations above 30 ng/mL.
Groups | Clinical Conditions |
---|---|
Elderly (> 65 years) | Osteoporosis (primary or secondary) |
Pregnant women | Fractures due to fragility |
Metabolic bone diseases (osteomalacia, osteogenesis imperfecta, primary hyperparathyroidism) Secondary hyperparathyroidism |
|
Sarcopenia | |
Recurring falls | |
Chronic renal disease | |
Malabsorption syndrome | |
Liver failure | |
Anorexia nervosa | |
Cancer |